News-Medical.Net on MSN
Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
20hon MSN
Multi-registry study highlights ocrelizumab's superior relapse control in multiple sclerosis
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback